There were 1,695 press releases posted in the last 24 hours and 413,069 in the last 365 days.

First Ethicon hernia mesh lawsuit to head to trial in 2018

Schmidt National Law Group now accepting cases

Schmidt National Law Group

Ethicon’s Physiomesh and other hernia mesh brands face litigation over risk of mesh-related complications

SAN DIEGO, CALIF., USA, February 22, 2017 /EINPresswire.com/ -- Ethicon Inc. will defend itself in the first Physiomesh hernia mesh lawsuit to go to trial next year.

The trial is scheduled for Jan. 22, 2018 in Illinois’ Southern District.

Ethicon Inc. is facing allegations that its hernia mesh product Physiomesh is causing an increasing number of complications in patients.

The Johnson & Johnson subsidiary withdrew Physiomesh from the market last year citing an increased risk of recurrence and revision surgery over other mesh brands.

Illinois resident Matthew Huff filed the Physiomesh lawsuit that is now scheduled to go to trial in January 2018.

Huff was implanted with Ethicon’s Physiomesh in 2013 to repair an abdominal wall hernia. Two years later he was back in the hospital after suffering from severe abdominal pain, fever, chills and redness on his abdomen, according to court documents.

Surgeons reportedly found an infection in and around the Physiomesh, which had caused significant damage to his abdomen and intestines. Huff suffered two abdominal abscesses and intestinal fistulas from the Physiomesh and required additional surgery, court documents indicated.

Huff filed his initial complaint against Ethicon on April 1, 2016, accusing the company of negligence, strict liability, and breach of warranty.

In the lawsuit, Huff accused Ethicon of designing what he called an “unreasonably dangerous” and defective product. He alleged Physiomesh was not adequately tested and said the product did not meet Ethicon’s usual standards and requirements.

Huff’s lawsuit (Case No. 3:16-cv-00368) will be the first Physiomesh lawsuit to go to trial and will be held before District Judge J. Phil Gilbert in the Southern District of Illinois.

The trial was originally scheduled for July 31, 2017, but was pushed back when Ethicon and Huff filed a joint motion to extend the date. The two parties said the extension was necessary because of the complex issues in the case.

Ethicon’s Physiomesh is not the only hernia mesh product under fire for potentially causing mesh-related complications in some patients.

Other problematic hernia mesh brands include:

• Atrium Medical’s C-Qur Hernia Mesh
• C.R. Bard’s Sepramesh
• C.R. Bard’s Ventralex ST Hernia Patch
• C.R. Bard’s 3DMAX Mesh

These hernia mesh brands have been linked to an increased risk of mesh-related complications, including:

• Inflammation
• Infection
• Chronic pain
• Hernia recurrence
• Adhesion
• Allergic reaction
• Tissue or mesh erosion
• Fistulas
• Need for additional surgeries (revision surgeries)

Hernia patients who experienced mesh-related complications may be able to file hernia mesh lawsuits of their own. Schmidt National Law Group is currently seeking claimants and is in the process of filing claims related to hernia mesh products and their possible side effects. Contact us today at 1-800-214-1010 or visit our website to learn more.

About Schmidt National Law Group

Schmidt National Law Group is a personal injury firm located in San Diego, Calif. Its team of experienced attorneys represents victims of all types of injuries, including those harmed by pharmaceutical drugs and medical devices.

Schmidt National Law Group’s team of attorneys, medical professionals, writers, and case managers fight every day for the rights of the injured. Martin Schmidt, a trial attorney with 30 years experience, has been recognized as a leading personal injury attorney and was chosen as one of the "Top 100 Trial Lawyers" by the American Association for Justice in 2015 and 2016.

Contact Us

Schmidt National Law Group
http://www.nationalinjuryhelp.com/
4241 Jutland Drive, Suite 200, San Diego CA, 92117
800-214-1010

Melissa Beltz
Schmidt National Law Group
800-214-1010 Ext. 370
email us here